Application 202774

Type
ANDA
Sponsor
JUBILANT GENERICS

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001BUPROPION HYDROCHLORIDEBUPROPION HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL100MGNoNo
002BUPROPION HYDROCHLORIDEBUPROPION HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL150MGNoNo
003BUPROPION HYDROCHLORIDEBUPROPION HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL200MGNoNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
59746-315Bupropion Hydrochloridebupropion hydrochlorideJubilant Cadista Pharmaceuticals Inc.ANDACurrent
59746-315Bupropion Hydrochloridebupropion hydrochlorideJubilant Cadista Pharmaceuticals Inc.ANDACurrent
59746-316Bupropion Hydrochloridebupropion hydrochlorideJubilant Cadista Pharmaceuticals Inc.ANDACurrent
59746-316Bupropion Hydrochloridebupropion hydrochlorideJubilant Cadista Pharmaceuticals Inc.ANDACurrent
59746-317Bupropion Hydrochloridebupropion hydrochlorideJubilant Cadista Pharmaceuticals Inc.ANDACurrent
59746-317Bupropion Hydrochloridebupropion hydrochlorideJubilant Cadista Pharmaceuticals Inc.ANDACurrent